A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Principal Investigator
Krishnan RamanathanOverview
Body Locations and Systems
Peripheral Arterial DiseaseClinicalTrials.gov#
NCT01732822Status
Closed for RecruitmentStudy Start/End
Mar 1, 2013 to Mar 1, 2018Locations
Diamond Health Care CentreName/Title
Research CoordinatorPhone
604-877-3728Purpose of Study
The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.